Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September
Portfolio Pulse from Benzinga Neuro
Novavax Inc. (NASDAQ: NVAX) shares surged 21.60% in pre-market trading after announcing plans to deliver a COVID-19 vaccine by September, following a recommendation from a U.S. regulatory advisory group.
June 06, 2024 | 12:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novavax Inc. shares surged 21.60% in pre-market trading after the company announced plans to deliver a COVID-19 vaccine by September, following a recommendation from a U.S. regulatory advisory group.
The announcement of delivering a COVID-19 vaccine by September, following a regulatory recommendation, has significantly boosted investor confidence, leading to a 21.60% surge in pre-market trading.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100